Update on Cervical Diseases - 2013

This course is designed to update clinicians with the dramatic changes that have occurred over the past 5-10 years in the understanding of causes, screening methods, prevention, identification, and management of cervical precancer.

In 2012, new unified screening guidelines were developed for cervical cancer and precancer and new consensus terminology was developed for lower anogenital tract squamous disease.

In 2013, management guidelines were developed for cytological and histological abnormalities. The mechanism of carcinogenesis of human papillomavirus (HPV) on the cervix will be discussed, along with the new evidence-based consensus guidelines that were developed to guide clinicians in screening for and the management of patients with cervical precancer.